Question follow-through · 52781
Drugs: UK Trade with EU
To ask the Minister for the Cabinet Office, what progress he has made in securing an agreement to remove the need to batch test medicines exported from the UK to the European Union.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Cabinet Office
- Tabled
- 15 May 2025
- Target answer date
- 19 May 2025
- Answer
- 27 May 2025 · 12 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Draft Code of Practice on Electronic and Workplace Ballots for Statutory Trade Union Ballots · 15 Jul 2026
- Draft Trade Unions (Permissible Means of Voting) and Employment Rights (Unfair Dismissal) (Amendment) Order 2026 · 15 Jul 2026
- Taxation (Energy and Vehicles) Bill Committee: New Clause 5 · 1 Jul 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
15 May 2025
Question tabled
To ask the Minister for the Cabinet Office, what progress he has made in securing an agreement to remove the need to batch test medicines exported from the UK to the European Union.
19 May 2025
Target answer date
Date supplied by the official written-questions record.
27 May 2025
Answer published
This Government is committed to reducing barriers to trade with the EU. We have secured a wide ranging deal with the EU that will reduce red tape, adding nearly £9 billion to our economy by 2040 and includes commitment to regular dialogue on economy and t...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.